Xcout IntelPthera, LLC
NeuroThera develops a clinical-grade transcranial photobiomodulation platform that delivers near-infrared laser light to targeted brain regions. The company's non-invasive technology aims to treat major neurological and psychiatric conditions, including major depressive disorder, Alzheimer's disease, Parkinson's disease, traumatic brain injury, and stroke recovery.
Subscribe to see Pthera, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pthera, LLC at a glance
Pthera, LLC is a medical devices company headquartered in United States. Its most recent funding round raised $400,000 in February 2016. Xcout tracks 8 named people at Pthera, LLC, including Paul Nielsen (Chief Executive Officer).
Pthera, LLC leadership
- Paul NielsenChief Executive Officer
- Dallas C. HackChief Scientific Officer
- Rhonda Robinson BealeChief Medical Officer
- Luis De TaboadaCTO & Co-Founder
- Brian PryorCo-Founder & Director
- Sean WangCo-Founder & Director
2 more named people on record for Pthera, LLC, with roles, board committees and tenure — see the full roster →
Pthera, LLC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $400,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Pthera, LLC competitors
A few of Pthera, LLC's closest competitors — see the full list of competitors and alternatives →
NeuroGlove, LLC develops a novel medical device designed to treat a variety of neurological and psychological conditions, including stroke, Parkinson's disease, PTSD, traumatic brain injury, anxiety, depression, and insomnia. The company serves patients and healthcare sectors by providing innovative treatment options aimed at transforming healthcare.
NeuroEM Therapeutics develops non-invasive medical technology to treat Alzheimer's disease. The company utilizes Transcranial Electromagnetic Treatment with Radio Frequencies (TEMT-RF) to target toxic brain proteins associated with cognitive decline in patients.
LumiThera, Inc. is an ophthalmic medical device company that harnesses the power of light to offer a comprehensive approach for detecting and treating eye conditions.
NeuroStar provides advanced, non-invasive transcranial magnetic stimulation (TMS) treatments designed for patients suffering from depression. The company is headquartered in Malvern, Pennsylvania, and offers physician-recommended in-office therapy.
Nocira, LLC is a pre-market medical device company developing an investigational treatment for migraine sufferers. Its non-invasive device delivers controlled pulses of air into the ear via a mobile app to stimulate sensory neurons and reset pain mechanisms in the brain.
Syqe Medical is a pharma-tech company that develops a precision inhalation platform designed to deliver central nervous system (CNS) drugs with pharmaceutical-grade accuracy. The company's technology features micro-dosing capabilities, consistent absorption technologies, and cloud-connected adherence tracking to optimize treatments for conditions such as diabetic peripheral neuropathic pain, PTSD, and insomnia.
Get Pthera, LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Pthera, LLC in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access